Literature DB >> 22460121

Metabolic disease: Identifying novel targets of resveratrol.

Katrin Legg.   

Abstract

Entities:  

Year:  2012        PMID： 22460121     DOI： 10.1038/nrd3717

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582
  1 in total
  3 in total

Review 1.  Organ-Protective Effects of Red Wine Extract, Resveratrol, in Oxidative Stress-Mediated Reperfusion Injury.

Authors:  Fu-Chao Liu; Hsin-I Tsai; Huang-Ping Yu
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

Review 2.  Anti-Inflammatory and Organ-Protective Effects of Resveratrol in Trauma-Hemorrhagic Injury.

Authors:  Fu-Chao Liu; Yung-Fong Tsai; Hsin-I Tsai; Huang-Ping Yu
Journal:  Mediators Inflamm       Date:  2015-07-26       Impact factor: 4.711

3.  Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli.

Authors:  Sun-Young Kang; Jae Kyoung Lee; Oksik Choi; Cha Young Kim; Jae-Hyuk Jang; Bang Yeon Hwang; Young-Soo Hong
Journal:  BMC Biotechnol       Date:  2014-07-17       Impact factor: 2.563
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.